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Background: Cryptosporidium hominis is a dominant species for human cryptosporidiosis. Within the species,
IbA10G2 is the most virulent subtype responsible for all C. hominis–associated outbreaks in Europe and Australia,
and is a dominant outbreak subtype in the United States. In recent yearsIaA28R4 is becoming a major new subtype
in the United States. In this study, we sequenced the genomes of two field specimens from each of the two
subtypes and conducted a comparative genomic analysis of the obtained sequences with those from the only fully
sequenced Cryptosporidium parvum genome.
Results: Altogether, 8.59-9.05 Mb of Cryptosporidium sequences in 45–767 assembled contigs were obtained from
the four specimens, representing 94.36-99.47% coverage of the expected genome. These genomes had complete
synteny in gene organization and 96.86-97.0% and 99.72-99.83% nucleotide sequence similarities to the published
genomes of C. parvum and C. hominis, respectively. Several major insertions and deletions were seen between
C. hominis and C. parvum genomes, involving mostly members of multicopy gene families near telomeres. The four
C. hominis genomes were highly similar to each other and divergent from the reference IaA25R3 genome in some
highly polymorphic regions. Major sequence differences among the four specimens sequenced in this study were
in the 5′ and 3′ ends of chromosome 6 and the gp60 region, largely the result of genetic recombination.
Conclusions: The sequence similarity among specimens of the two dominant outbreak subtypes and genetic
recombination in chromosome 6, especially around the putative virulence determinant gp60 region, suggest that
genetic recombination plays a potential role in the emergence of hyper-transmissible C. hominis subtypes. The high
sequence conservation between C. parvum and C. hominis genomes and significant differences in copy numbers of
MEDLE family secreted proteins and insulinase-like proteases indicate that telomeric gene duplications could
potentially contribute to host expansion in C. parvum.
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Cryptosporidium spp. inhabit the brush borders of the
gastrointestinal and respiratory epithelium of various
vertebrates, causing enterocolitis, diarrhea, and cholan-
giopathy in humans [1]. Immunocompetent children and
adults with cryptosporidiosis usually have a short-term
illness accompanied by watery diarrhea, nausea, vomit-
ing, and weight loss. In immunocompromised persons,
however, the infection can be protracted and life-
threatening [2]. Cryptosporidiosis is one of the most im-
portant causes of moderate-to-severe diarrhea and
diarrhea-associated deaths in children in developing
countries [3] and a major cause for waterborne and
foodborne outbreaks of human illness in industrialized
nations [4,5]. In the United States the number of
reported cases of cryptosporidiosis has increased more
than twofold since 2005 [6-9]. Currently, it is estimated
that there are approximately 750,000 annual cases of
cryptosporidiosis in the United States [5].
Among the many established Cryptosporidium species
and genotypes, C. hominis and C. parvum are the two
responsible for greater than 90% of the human crypto-
sporidiosis cases in most countries. C. hominis is largely
human-specific and responsible for anthroponotic trans-
mission of cryptosporidiosis. C. parvum infects both
humans and some farm animals, especially pre-weaned
calves and lambs and thus can be transmitted both
anthroponotically and zoonotically [10]. Within C. homi-
nis, subtype IbA10G2 is the dominant strain for C.
hominis-associated waterborne outbreaks of cryptospor-
idiosis in the United States, Europe, and Australia
[10-16]. The dominant subtype associated with water-
borne cryptosporidiosis outbreaks in the United States
since 2005 is a new subtype, IaA28R4 [17-20].
Whole genome sequencing of Cryptosporidium spp.
has greatly facilitated the development of genotyping,
subtyping and multilocus sequence typing (MLST) tools
for characterizing the transmission of C. hominis and C.
parvum [21,22]. These tools have played a major role in
improving our understanding of cryptosporidiosis epi-
demiology [10,23]. Nevertheless, genomic studies of
Cryptosporidium spp. lag far behind those on other re-
lated apicomplexan parasites largely because of the lack
of effective cultivation and animal models. Thus far,
only the genomes of one laboratory isolate each of C.
parvum, C. hominis, and C. muris have been sequenced
using traditional Sanger sequencing technology [22,24,25].
More recently, the genome of an anthroponotic II subtype
(IIcA5G3b) of C. parvum serially propagated in immuno-
suppressed mice has been sequenced using Illumina tech-
nology [26]. The lack of whole genome sequence data,
especially from field specimens obtained from outbreaks,
has hampered our understanding of genetic determinants
for host specificity, virulence, and the biological fitness ofvarious Cryptosporidium species and C. parvum and C.
hominis subtypes.
In this study, we sequenced the genomes of two domin-
ant outbreak subtypes (IbA10G2 and IaA28R4) of C.
hominis by using 454 and Illumina technologies. Prior to
sequencing, oocysts were isolated directly from field speci-
mens without propagation in laboratory animals, and
extracted DNA was amplified to generate enough material
for sequencing. Results of this study have (1) filled some
gaps in our understanding of Cryptosporidium genomics,
(2) identified some major deletions and one large insertion
in the C. hominis genome, and (3) showed the high
genetic similarity of the two outbreak subtypes. We have
also demonstrated the occurrence of genetic recombin-
ation in chromosome 6.
Results
Cryptosporidium hominis sequence data and de novo
assemblies
After sequencing using 454 technology, 1,048,412 reads
(382.5 Mb) were obtained from specimen 30974
(IbA10G2) and 1,157,140 reads (431.7 Mb) were obtained
from specimen 33537 (IaA28R4). They produced an
assembly of 8,841,752 bp in 443 contigs for specimen
30974 (N50 = 78,110 bp) and an assembly of 14,065,231 bp
in 1,464 contigs for specimen 33537 (N50 = 27,749 bp).
Using Illumina paired-end sequencing, 64,449,544 reads
(5,780.0 Mb) were obtained from specimen 30976
(IaA28R4) and 30,886,077 reads (2,798.3 Mb) were ob-
tained from specimen 37999 (IbA10G2). They produced
an assembly of 22,133,082 bp in 6,140 contigs for speci-
men 30976 (N50 = 145,968 bp) and 9,054,010 bp in 78
contigs for specimen 37999 (N50 = 406,678 bp; Table 1).
Genome coverage and bacterial contamination
Among the two specimens sequenced by 454 technol-
ogy, 424 of the 443 contigs generated from the IbA10G2
specimen 30974 and 767 of the 1,464 contigs from the
IaA28R4 specimen 33537 mapped to the eight chromo-
somes of the C. parvum IOWA isolate, representing
8,816,174 and 8,590,919 bp, thus giving a 96.9% and
94.4% coverage of the genomes, respectively (Table 2,
Additional file 1: Figure S1). The C. parvum genome
was used as the reference because it is the most
complete genome fully assembled into eight chromo-
somes with the aid of a physical HAPPY map generated
prior to the sequencing effort [27], and has ~97% se-
quence similarity to the reference C. hominis TU502
(IaA25R3) genome. The latter has 1,422 scaffolds and
contigs, but was estimated to have synteny to many con-
tigs in the C. parvum IOWA (IIaA15G2R1) genome
sequences [25]. For the two specimens sequenced by
paired-end Illumina, 64 of the 78 contigs generated from
the IbA10G2 specimen 37999 and 45 of the 6,140
Table 1 Summary of sequence data from whole genome sequencing of four Cryptosporidium hominis specimens in
comparison with data from the published C. hominis (TU502) and C. parvum (IOWA) genomes
Specimen
(gp60
subtype)
Technique Total
nucleotides
Total
sequence
reads
Assembly Average
coverage
(fold)
# of
Contigs
Length
(bp)
Mean
(bp)
Minimum
(bp)
Maximum
(bp)
N50
(bp)
30976
(IaA28R4)
Illumina Genome
Analyzer IIx 100 bp
paired end
5,780,028,818 64,449,544 6,140 22,133,082 3,605 502 1,279,890 145,968 257
37999 (IbA10G2) Illumina Genome
Analyzer IIx 100 bp
paired end
2,798,259,889 30,886,077 78 9,054,010 116,077 510 1,029,232 406,678 307
33537 (IaA28R4) 454 GS-FLX
Titanium
431,742,212 1,157,140 1,464 14,065,231 9,607 501 154,507 27,749 31
30974 (IbA10G2) 454 GS-FLX
Titanium
382,520,957 1,048,412 443 8,841,752 19,959 513 325,032 78,110 43
C. hominis TU502
(IaA25R3)
Sanger - - 1,422 8,743,570 6,149 251 90,444 14,504 12
C. parvum IOWA
(IIaA15G2R1)
Sanger - - 18 9,102,324 504,874 17,388 1,278,458 1,014,526 13
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the eight chromosomes of the C. parvum reference gen-
ome. The mapped contigs represented 9,041,990 and
9,054,312 bp and thus had 99.34% and 99.47% coverages
of the genomes, respectively. In contrast, 1,269 of 1,422
contigs from the published genome of TU502 (IaA25R3)
mapped to the eight C. parvum chromosomes, represent-
ing a 95.5% coverage (Table 2, Figure 1A). No physical
map is available for any of the C. hominis specimens
sequenced to date to aid the assembly of genomic
sequences.
Most of the 14 unmapped contigs from specimen 37999
were small (≤1,824 bp) and were sequences of multicopy
genes (ex. rRNA units) and genes with paralogs in the
genome or large repetitive sequences (ex. fatty acid syn-
thase and cgd5_1210 and cgd5_1220). However, sequences
of four contigs (45, 66, 74, and 77) had no similarity to
any published sequences, and one contig (#76) had 95%
sequence similarity to a 500-bp region of the genome of
Strentrophomonas maltophilia (CP002986). Similarly,
most of the unmapped contigs from specimen 30974 were
small (≤3,170 bp) and were sequences of multicopy genes
(ex. rRNA units), genes with paralogs in the genome and
large repetitive sequences (ex. fatty acid synthase and
cgd5_2180), and telomeric sequences of Cryptosporidium.
Sequences of 18 contigs (#303, 357, 392, 415, 416, 436,
492, 503, 521, 524, 529, 537, 542, 543, 551, 562, 563, and
564) had no similarity to any published Cryptosporidium
sequences, and one contig (#392) had 98-100% sequence
similarity to Bacteroides fragillis plasmids from humans
(AB646744 and U25716). Similar observations were made
for TU502. In addition, the 547 bp at the 5′ end of contig
AAEL01000108 (19,113 bp) had 98% sequence similarity
to cgd3_530 on chromosome 3, while the remaining part
of the sequence mapped to chromosome 8. Similarly, the5′ (15,709-bp) region of contig AAEL01000024 (36,266 bp
in length) mapped to chromosome 7, the 3′ region (nucle-
otides 25,790-36,266) mapped to chromosome 2, while
the middle region containing the rRNA unit mapped to
chromosomes 1, 2, 7, and 8.
In contrast, most of the unmapped contigs from
IaA28R4 specimens 30976 and 33537 had non-Crypto-
sporidium sequences. For example, the largest 100 un-
mapped contigs (16,411-138,945 bp) from specimen
33537 were 99-100% similar to the genome (CP006252) of
the enterobacteria Serratia liquefaciens, with the exception
of contig 0018 (94,132 bp), which was from its plasmid. As
the genome of S. liquefaciens is about 5.2 Mb, the 1,464
contigs of 14,065,231 bp from specimen 33537 were from
the combined C. hominis and S. liquefaciens genomes, with
all S. liquefaciens contigs positioned behind the mapped
Cryptosporidium sequences (Additional file 1: Figure S1).
Evidence of contamination from several bacterial species
was present in data from specimen 30976, as the 6,140
contigs totaled 22.13 Mb, which is larger than the com-
bined genomes of C. hominis and one bacterial species.
BLAST analysis of contigs indicated that ~28% of the total
nucleotides were from members of Enterobacteriaceae and
8% from Bacteroidaceae. The 20 largest unmapped contigs
(88,676-515,888 bp) had 75-85% sequence similarities to
genomes of members (Serratia, Yersinia, Klebsiella, E. coli,
Salmonella, etc.) of Enterobacteriaceae, except for one
(contig #51), which had a 98% sequence similarity to a
21,307 bp region of an uncultured organism from the hu-
man gut (GQ873945).
Sequence similarity to published C. parvum genome and
physical characteristic of C. hominis genomes
The genomes of specimens 30974, 30976, 33537, 37999
and TU502 had 96.90%, 96.87%, 97.0%, 96.86%, and
Table 2 Coverage of four Cryptosporidium hominis genomes sequenced in this study and sequence similarities to published C. parvum (IOWA) and C. hominis
(TU502) genomes
C. parvum
length (bp)
37999 (IbA10G2) 30976 (IaA28R4)
Contigs
mapped
Length (bp) Coverage (%) Similarity to
IOWA (%)
Similarity to
TU502 (%)
Contigs
mapped
Length (bp) Coverage (%) Similarity to
IOWA (%)
Similarity to
TU502 (%)
1 875659 15 867575 99.08 96.8 99.79 1 873289 99.73 96.81 99.86
2 985969 7 987017 100.11 96.79 99.58 8 983830 99.78 96.82 99.81
3 1099352 13 1098355 99.91 96.89 99.62 13 1096430 99.73 96.86 99.79
4 1104417 3 1103687 99.93 96.76 99.72 4 1105075 100.06 96.76 99.8
5 1080900 13 1092751 101.1 96.78 99.74 11 1107822 102.49 96.78 99.84
6 1332857 5 1304591 97.88 96.91 99.76 2 1298888 97.45 96.93 99.86
7 1278458 5 1268482 99.22 97.19 99.79 4 1269257 99.28 97.2 99.87
8 1344712 3 1319172 98.1 96.78 99.76 2 1319721 98.14 96.8 99.83
Total 9102324 64 9041990 99.34 96.86 99.72 45 9054312 99.47 96.87 99.83
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Table 2 Coverage of four Cryptosporidium hominis genomes sequenced in this study and sequence similarities to publ hed C. parvum (IOWA) and C. hominis
(TU502) genomes (Continued)
C. parvum
length (bp)
30974 (IbA10G2) 33537 (IaA28R4) TU502 (IaA25R3)
Contigs
mapped
Length
(bp)
Coverage
(%)
Similarity to
IOWA (%)
Similarity to
TU502 (%)
Contigs
mapped
Length
(bp)
Coverage
(%)
Similarity to
IOWA (%)
Similarity t
TU502 (%)
Contigs
mapped
Length
(bp)
Coverage
(%)
Similarity to
IOWA (%)
1 875659 36 863586 98.62 96.84 99.82 54 840604 96 96.93 99.86 124 859754 98.18 96.88
2 985969 41 970191 98.4 96.81 99.77 69 944487 95.8 96.9 99.82 115 946071 95.95 96.73
3 1099352 40 1081251 98.35 96.86 99.75 87 1064015 96.78 96.98 99.81 158 1079381 98.18 96.78
4 1104417 86 1056974 95.7 96.81 99.74 123 1024384 92.75 96.93 99.82 195 1007110 91.19 96.77
5 1080900 71 1013283 93.74 96.93 99.77 118 940540 87.01 97.09 99.83 186 972978 90.02 96.79
6 1332857 66 1263267 94.78 97.01 99.76 124 1237394 92.84 97.09 99.83 192 1240122 93.04 96.82
7 1278458 27 1267106 99.11 97.18 99.82 79 1258429 98.43 97.25 99.88 124 1282777 100.34 97.18
8 1344712 57 1300516 96.71 96.81 99.78 113 1281066 95.26 96.9 99.81 175 1304075 96.98 96.74
Total 9102324 424 8816174 96.93 96.9 99.78 767 8590919 94.36 97 99.83 1269 8692268 95.49 96.84
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Figure 1 Structural organization of two Illumina-sequenced genomes of Cryptosporidium hominis comparing to eight chromosomes (numbered and
separated by vertical red lines) of published Cryptosporidium parvum genome. The color blocks (known as Locally Collinear Blocks) are
conserved segments of sequences internally free from genome rearrangements, whereas the inverted white peaks within each block are
sequence divergence between the reference C. parvum (IOWA) genome and C. hominis genome under analysis. A. Coverage of two C.
hominis genomes showing possible sequence rearrangements in chromosomes 2, 4, 5 and 6. Assembled contigs are bordered by vertical
red lines. For specimens 30976, only Cryptosporidium contigs were used in mapping. B. Possible sequence rearrangements at the 5′ end
of chromosome 2. C. Possible sequence rearrangements in chromosomes 4 and 5.
Guo et al. BMC Genomics  (2015) 16:320 Page 7 of 1896.84% sequence similarities to the C. parvum IOWA
genome in the mapped regions, respectively (Table 2).
The alignment of whole genome sequences generated by
Mauve showed near complete sequence synteny of the
four C. hominis genomes to the published C. parvum
reference genome, which is the only complete Cryp-
tosporidium genome available for comparison. Some
possible inversions and translocations of sequence frag-
ments were seen in chromosomes 2, 4, 5 and 6 in the
two almost fully sequenced C. hominis genomes from
specimens 30976 and 37999 (Figure 1A). However, these
inversions and translocations all occurred in sequence
gap regions of the reference C. parvum genome. For ex-
ample, specimens 30976 and 37999 generated sequences
that cover the sequence gap in chromosome 2 of the C.
parvum genome and have ~4,600-bp extra sequences at
the 5′ end of the fragment, with telomeric repeats
(TTTAGG) (Figure 1B). The inversions of sequences in
chromosomes 4 and 5 also happened around sequence
gaps in the C. parvum IOWA genome (Figure 1C). Near
the 3′ end of chromosome 5, the large C. hominis con-
tigs in 30976 and 37999 that are upstream of the two
small scaffolds (coding for cgd5_4510 to cgd5_4610) in
the C. parvum IOWA genome both end with telomeric
repeats (data not shown). Similarly, the large C. hominis
contigs in 30976 and 37999 that are upstream of the
small scaffold (coding for cgd6_5460 to cgd6_5520) at
the 3′ end of chromosome 6 in the C. parvum IOWA
genome both end with telomeric repeats. In addition,
one or two of the genes coded by the C. parvum scaffold
(cgd6_5460 for specimen 37999 and cgd6_5460 and
cgd6_5470 for specimen 30976) are located at the 5′
end of chromosome 5 in C. hominis, which has telo-
meric repeats at the 5′ end (Figure 2A). Most of the
remaining genes are missing in C. hominis, except for
cgd6_5500, whose ortholog is present in C. hominis in
an unknown chromosome together with the ortholog of
cgd5_4600. Although the genome sequences of specimens
30974 and 33537 were more fragmented, the same inver-
sion of scaffolds was seen in chromosome 5 (Additional
file 1: Figure S1).
Most of the missing sequences in the sequenced
genomes were in the telomeric regions or low sequence
complexity areas of the eight chromosomes of C. parvum,
and generally occurred in the two 454-sequenced and thepublished C. hominis genomes. Half of the ten sequence
gaps (unsequenced regions present in clones) in the C.
parvum genome were missing in the 454-sequenced and
the published C. hominis genomes (data not shown). The
two Illumina-sequenced genomes, however, fully covered
most of the ten sequence gaps in the C. parvum IOWA
genome (Table 3). Most of the sequences generated
from C. hominis specimens 30976 and 37999 were lon-
ger than the estimated length of sequence gaps in the
C. parvum IOWA genome, with the noticeable excep-
tion of the ~10,000-bp sequence gap in C. parvum, which
is not present in all five C. hominis genomes (Table 3).
This region was fully covered by contig 11 of 30976, contig
2 of 37999, contig 0057 of 30974, contig 0792 of 33537,
and contig 212 (AAEL01000212) of TU502 (Figure 2B). In
C. hominis, the ~100 bp sequence downstream of the
deletion is almost identical to the beginning sequence of
the insert and the immediate sequence downstream of the
insert in C. parvum. This might have contributed to the
large deletion in the C. hominis genome. The size of the
deletion was 19,048 bp if the sequence gap in C. parvum
was indeed 10,000 bp.
C. parvum- and C. hominis- specific sequences
In addition to the large 19,048-bp deletion, which
contained the C. parvum-specific cgd8_680 and cgd8-
690 genes and other potential genes in the ~10,000-bp
sequence gap, the comparative genomic analysis iden-
tified several other deletions in the C. hominis genome
(Table 4), including those mentioned above at the
3′ end of chromosomes 5 (containing orthologs of
cgd5_4580, cgd5_4590, and cgd5_4610) and 6 (con-
taining orthologs of cgd6_5480, cgd6_5490, cgd6_5510,
and cgd6_5520). Most of the C. parvum-specific genes were
members of multicopy gene families. Thus, cgd5_4580,
cgd5_4590, cgd5_4600, cgd5_4610, cgd6_5480, and cgd6_
5490 in C. parvum are genes of the Cryptosporidium telo-
meric MEDLE family of secreted proteins, all with signal
peptides and similar sequences. As mentioned above, these
genes are located in tandem in telomeric regions of these
two chromosomes, but C. hominis has only one such
gene, Chro.50507 or the ortholog of cgd5_4600. Like-
wise, cgd6_5510 and cgd6_5520 both code for telomeric
insulinase-like proteases with signal peptides. Members
of the insulinase-like proteases all have very different
AB
Figure 2 Deletion of genes in Cryptosporidium hominis genomes in comparison with Cryptosporidium parvum. A. Deletion of four genes (cgd6_5480,
cgd6_5490, cgd6_5510, and cgd6_5520) at the 3′ end of chromosome 6 (probably should be the 5′ end of chromosome 5) in C. hominis. B. A major
19,048-bp deletion in C. hominis genome in chromosome 8, including the cgd8_680 and cgd8_690 genes. Note the ~10 kb sequence gap in
C. parvum.
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nis have 11 such genes in tandem near the 3′ end of
chromosome 3. Thus, C. hominis lacks two of the subte-
lomeric genes at the 5′ end of chromosome 5 as well asfive copies of the Cryptosporidium telomeric MEDLE
family of secreted proteins in chromosomes 5 and 6.
The C. parvum-specific nature of cgd6_5510 (also
known as ZPT) was previously known [28].
Table 3 Coverage of two Illumina-sequenced Cryptosporidium hominis genomes in sequence gaps of the published C.
parvum IOWA genome
Chromosome Gap in C. parvum
IOWA (bp)
Sequence length in C. hominis specimen (bp)
37999 30976
2 100* 1481 1481
3 500 5582 5576
4 100 (1st)* >458 1450
4 100 (2nd)* 2937 2714
5 100 (1st)* 14,926 14,929
5 100 (2nd)* 1788 1311
5 1,000 (3rd) Not covered 467
6 2,500 245 245
6 100* >538 (ending with telomeric repeats) >857 (ending with telomeric repeats)
8 10,000 19,048 bp deletion spanning entire gap 19,048 bp deletion spanning entire gap
*Regions where inversions and translocations of sequences occurred in sequenced C. hominis genomes.
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eral large contigs not found in the published C. par-
vum IOWA genome, including contigs AAEL01000413,
AAEL01000717, and AAEL01000728 in the published
TU502 genome. Contig AAEL01000413 is 6,056 bp in
length (29% GC) and has 260 copies of telomeric sequence
TTTAGG at its 3′ end. It mapped to contigs 442 and 290
of specimen 30974 and contigs 1743, 1586, and 768 of
specimen 33537, and was fully covered by contig 82 of
specimen 30976 and contig 35 of specimen 37999. It codes
at nucleotides 1,798-3,267 for the hypothetical protein
Chro. 50011 with RS/HS repeats at the carboxyl end. The
coding region was fully covered in all C. hominis genomes
sequenced in this project. Sequence alignment indicates
that the gene is located at the 3′ end of chromosome 3,
with the entire insertion (4,795 bp in 30976 and 4,830
bp in 37999, excluding telomere repeats) all ending
with copies of the telomere repeat sequence TTTAGGTable 4 Species-specific genes in genomes of Cryptosporidium
Chromosome Length (bp) Genes
8 19,048 cgd8_680, cgd8_690 and
6 15,314 cgd6_5480, cgd6_5490, c
5 5,620 cgd5_4580, cgd5_4590, c
3 ~4800 Chro.50011
Notes:
1. cgd5_4580, cgd5_4590, cgd5_4600, and cgd5_4610: four genes with similar sequ
family of secreted proteins. C. hominis has only one such gene here (Chro.50507, th
2. cgd6_5480 and cgd6_ 5490: two genes of the telomeric MEDLE family of secrete
hominis has no such gene here. The two genes have sequences similar to the four
located at the 5′ end of chromosome 5 in the C. hominis genomes sequenced. C. ho
although 30976 clearly has it. Ortholog of cgd6_5500 is apparently translocated to
of cgd5_4580.
3. cgd6_5510 (ZPT) and cgd6_5520: telomeric insulinase-like protease with a signal
genes near 3′end of chromosome 3.
4. cgd8_680: a large low complexity protein with repeats. cgd8_690: a signal peptid
its ortholog chro.80081).(Figure 3A). As the 3′ end of chromosome 3 of C. parvum
also had the telomeric repeats, this insertion appears valid.
The coding region is not present in C. parvum EST
library data and five MS/MS peptide libraries depos-
ited in CryptoDB (http://cryptodb.org/cryptodb/). PCR
amplification of DNA from five C. parvum and C.
hominis specimens each confirmed its presence in
only C. hominis (Figure 3B).
In contrast, contig AAEL01000728 is 2,277 bp in
length (23% GC) and mapped to contig 257 of specimen
30974 and contigs 1238, 1367, and 1487 of specimen
33537. It is located in chromosome 5 of specimens
30976 (contig_6) and 37999 (contig_1), and within a
sequence gap area in the C. parvum IOWA genome.
PCR analysis using primers based on the AAEL01000728
sequence amplified DNA of C. hominis, C. parvum, and
C. andersoni, with the sequences from C. parvum and C.
hominis differing from each other by two nucleotides inparvum and C. hominis
Specificity
other potential genes in 10,000 bp sequence gap C. parvum
gd6_5510, cgd6_5520 C. parvum
gd5_4610 C. parvum
C. hominis
ences at the 3′ end of chromosome 5 in C. parvum, all called telomeric MEDLE
e ortholog of cgd5_4600).
d proteins with similar sequences at 3′ end of chromosome 6 in C. parvum. C.
genes above. This fragment and cgd6_5510 (ZPT) and cgd6_5520 below are
minis specimen 37999 does not appear to have the ortholog for cgd6_5470,
an unknown chromosome in C. hominis, downstream of the ortholog
peptide (the two genes have very different sequences). C. parvum has 11 such
e containing protein with 2 Cryptosporidium-specific paralogs (cgd8_660 and
AB
Figure 3 Cryptosporidium hominis-specific nature of Chro.50011. A. Insertion of ~4,860 bp containing the Chro.50011 gene at the 3′ end of
chromosome 3 in C. hominis. B. Confirmation of the absence of the ortholog of Chro.50011 in four specimens of C. parvum by PCR analysis of
three regions of the Chro.50011 gene. The faint band in PCR analysis of the 3′ end of the gene in C. parvum specimen 38416 produced a
nucleotide sequence identical to Chro.50011 in C. hominis.
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97% sequence similarity to nucleotide 19,798-20,202 of
XM_002142452 (coding for a large hypothetical protein
CMU_010870) from C. muris (data not shown). Contig
AAEL01000717, which contains the sensor histidine kin-
ase gene (Chro.00003, nucleotide 673–2,319), was prob-
ably not of Cryptosporidium origin. It is 2,333 bp in
length had a 66% GC content. It has no equivalents in
the published C. parvum and C. muris genomes and C.
hominis genomes sequenced in the present study, but has
a 77% sequence similarity to the sensor histidine kinase
gene of Rhizobium etli (nucleotides 1,334,700-1,334,429 of
CP001074). PCR primers based on this sequence did not
amplify DNA of C. parvum or C. hominis (data not
shown).
Sequence similarity to published C. hominis genomic data
The genomes of specimens 30974 (IbA10G2), 30976
(IaA28R4), 33537 (IaA28R4), and 37999 (IbA10G2) had
99.78%, 99.83%, 99.83%, and 99.72% sequence similar-
ities to the published C. hominis genome of TU502 (of
the IaA25R3 subtype), respectively (Table 2). Mapping of
Illumina reads from specimens 30976 and 37999 to the
contigs of the published C. hominis TU502 genome indi-
cated that single nucleotide polymorphisms (SNPs) were
distributed across all eight chromosomes of the genome.
A few loci on several chromosomes, however, had higher
sequence polymorphisms (Figure 4A, Additional file 2:
Figure S2). Most of the highly polymorphic loci occurred
in genes coding for mucins (orthologs of cgd2_430,
cgd2_440, cgd2_450, cgd3_720, and cgd6_1080 or gp60),
other secreted proteins with signal peptides (orthologs
of cgd1_150, cgd1_3810, cgd3_3430, cgd6_1030, and
cgd6_5270), and proteases (orthologs of cgd3_4260 and
cgd6_60) (Table 5). A CryptoDB search of transcriptome
data generated from an in vitro culture of C. parvum
previously by real-time PCR [29] indicated that most of
the genes are differentially expressed at various develop-
mental stages.
Sequence similarity among sequenced C. hominis
genomes and occurrence of genetic recombination
The genomes of the four C. hominis specimens se-
quenced in this study were similar to each other, except
for a subtelomeric region at the 3′ end of chromosome
1 and three regions on chromosome 6. This was sup-
ported by SNP analyses through both mapping of Illu-
mina reads to assembled contigs (Figure 4B) and direct
comparison of sequence alignments of assembled contigs.
At the 3′ end of chromosome 1 (within Chro.10427 or the
ortholog of cgd1_3810), two types of sequences were seen
among the specimens sequenced in this study: one from
the two IbA10G2 specimens (30974 and 37999) and an-
other from the two IaA28R4 specimens (30976 and33537). Both were very divergent from the sequence in
TU502 (Figure 4, Additional file 2: Figure S2). In contrast,
at the three loci in chromosome 6, the sequence poly-
morphism was biallelic, with each genome showing one of
the two types of nucleotide sequences, including the refer-
ence C. hominis genome (Table 6). Thus at the 5′ end of
the chromosome (containing Chro.60016, the ortholog of
cgd6_60, coding for a protease), all specimens except for
specimen 30974 had sequence identical to the published
sequence from TU502 (Additional file 3: Figure S3). At
the gp60 locus (Chro.60138, the ortholog of cgd6_1080: a
well-known subtyping locus for Cryptosporidium), speci-
mens 30974 and 37999 had the Ib type sequence whereas
others, including TU502 had the Ia type sequence. Simi-
larly at the 3′ end of the chromosome downstream of
Chro.60606 (the ortholog of cgd6_5270), specimens 30974
and 37999 had sequences similar to the published se-
quence from TU502, whereas specimens 30976 and
33537 had a different type of sequence (Figure 4, Add-
itional file 2: Figure S2, Table 6). The breakpoints for
the three genetic recombination areas occurred at inter-
genic regions upstream and downstream of cgd6_60
(ortholog: Chro.60016), upstream of cgd6_1000 (ortholog:
Chro.60130) and downstream of cgd6_1100 (ortholog:
Chro.60142), and upstream of cgd6_5240 (ortholog:
Chro.60603) and downstream of cgd6_5320 (its ortholog
in C. hominis is unnamed) for the three regions, respect-
ively. Because of the occurrence of genetic recombination,
the two IbA10G2 specimens (30974 and 37999) se-
quenced in the study had different types of sequence at
the 5′ end of chromosome 6 (Table 6).
Intra-specimen sequence diversity at the trinucleotide
repeat region of gp60
Because of a recent report on intra-specimen genetic
heterogeneity seen in Illumina sequencing of a PCR-
WGA product from a C. parvum specimen [30], we
examined intra-specimen sequence diversity at the trinu-
cleotide repeat region of the gp60 gene in the four C.
hominis specimens sequenced in this study. In the speci-
mens sequenced by using 454 technology, 205 and 310
sequence reads mapped to the gp60 gene for specimens
30974 and 33537, respectively. Among them, 78 and 59
reads had sequences fully covering the entire trinucleo-
tide repeats for the IbA10G2 and IaA28R4 subtypes,
respectively. No intra-specimen sequence diversity was
seen (Additional file 4: Figure S4, Additional file 5:
Figure S5). Similarly, 2,781 and 5,576 sequence reads
mapped to the gp60 gene in specimens 37999 and 30976
sequenced by using Illumina, respectively. Among them,
73 and 30 reads had sequences fully covering the entire
trinucleotide repeats for the IbA10G2 and IaA28R4 sub-
types, respectively. No intra-specimen diversity was seen
in specimen 37999, whereas in 30976 (of the IaA28R4
A B
Figure 4 (See legend on next page.)
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Figure 4 Distribution of SNPs in Cryptosporidium hominis genome by chromosome. The number of SNPs in a sliding window of 2,000 bp with
200 bp steps across each of the eight chromosomes is shown. A. Sequence divergence between specimen 30976 of the IaA28R4 subtype and
the published isolate TU502 of the IaA25R3 subtype. B. Sequence divergence between specimen 37999 of the IbA10G2 subtype and specimen
30976 of the IaA10G2 subtype.
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had 27 copies of the TCA repeat, and one had 29 copies of
the TCA repeat (data not shown).
Discussion
Genome similarity between C. hominis and C. parvum,
gene deletions, and species-specific genes
Results of this study have confirmed the genetic similarity
between the almost fully sequenced C. parvum and C.
hominis genomes. The genomes of the two species are
nearly 97% similar in nucleotide sequences, with complete
synteny in gene organization. This is similar to the previ-
ous conclusion based on comparison of the fully assem-
bled genome of the C. parvum IOWA isolate and the
more fragmented genome from the C. hominis TU502
isolate [24,25]. Some potential genetic rearrangements in
several chromosomes were observed in the current study,
but they all occurred in the ten sequence gaps and several
sequence ambiguity areas in the reference C. parvum gen-
ome. As there are no HAPPY maps and genomic libraries
with large inserts for C. hominis, the observations on gen-
ome organization of C. hominis need to be supported by
PacBio sequencing. Nevertheless, comparative genomic
analysis in this study has identified several major deletions
and one insertion in C. hominis, which were overlooked in
previous studies probably because of the fragmented na-
ture of the published C. hominis genome. The significance
of these gene insertions and deletions (indels) is not clear.Table 5 Highly polymorphic loci in Cryptosporidium hominis g
Locus Contig in 30976 SNP/kb
(30976 vs Tu502)
Gene in C. hominis*
chr1_var1 contig_5 5.0 Chro.10024
chr1_var2 contig_5 9.0 Chro.10427
chr2_var1 contig_32 9.5 Chro.20050-52
chr2_var2 contig_20 5.0 Intergenic downstream
of Chro.20394
chr3_var1 contig_59 5.0 Intergenic downstream
of Chro.30096
chr3_var2 contig_31 6.5 Chro.30315
chr3_var3 contig_293 +
contig_255
7.0 Chro.30479
chr6_var1 contig_3 9.0 Chro.60606
chr8_var1 contig_11 5.5 Chro.80070
chr8_var2 contig_2 6.0 Chro.80189
*Additional polymorphic genes identified by comparative analysis of other isolates
(ortholog of cgd6_1080).Because of the high sequence similarity in most genes be-
tween C. parvum and C. hominis, these major indels could
potentially be responsible for some biological differences
between C. parvum and C. hominis.
Gene duplication and interallelic recombination could
contribute to the gene expansion and losses seen between
C. parvum and C. hominis genomes. Most of the genes
deleted in the C. hominis genome are members of mul-
tigene families and have paralogs nearby. Thus, of the
six MEDLE family of secreted protein genes possibly
present in tandem in C. parvum (cgd5_4580, cgd5_4590,
cgd5_4600, cgd5_4610, cgd6_5480, and cgd6_ 5490), only
one, the ortholog of cgd5_4600, is present in C. hominis.
Similarly, two genes (cgd6_5510 and cgd6_5520) that code
for insulinase-like are absent in C. hominis. The subtelo-
meric locations of these genes facilitate the expansion and
deletions of multicopy genes by interallelic recombination.
Sequence homology is probably also involved in the loss
of cgd8_680 and cgd8_690 orthologs in chromosome 8 of
C. hominis, as the ~100 bp region upstream of the frag-
ment containing the two genes and the ~100 bp region
downstream of the fragment have almost identical
sequences. The sequence homology in two nearby regions
could have resulted in the deletion of the two genes in C.
hominis during species evolution. As cgd8_690 is a para-
log of cgd8_660 and has some sequence similarity to the
5′ end of cgd8_670, this gene loss in chromosome 8 of C.
hominis also involves a multigene family. In compactenomes
Ortholog in
C. parvum*
Annotation
cgd1_150 Hypothetical protein with a signal peptide
cgd1_3810 Conserved hypothetical protein with a signal
peptide
cgd2_430-450 Mucin glycoprotein with a signal peptide
Intergenic downstream
of cgd2_3690
WD repeat protein (cgd2_3690)
Within cgd3_720 Very large mucin with a signal peptide
cgd3_2770 Hypothetical conserved protein
cgd3_4260 Insulinase-like protease
cgd6_5270 Hypothetical protein with a signal peptide
cgd8_550 Large uncharacterized protein
cgd8_1610 Sacsin-like HSP90 chaperone domain
with C. hominis TU502: Chro.60016 (ortholog of cgd6_60), and Chro.60138
Table 6 Genetic recombination in chromosome 6 of two virulent Cryptosporidium hominis subtypes
Specimen
(subtype)
Sequence characteristics
5′ end (cgd6_60) gp60 area (cgd6_1000-cgd6_1100) 3′ end (cgd6_5240-cgd6_5320)
30974 (IbA10G2) IbA10G2 IbA10G2 IaA25R3
37999 (IbA10G2) IaA25R3* IbA10G2 IaA25R3
30976 (IaA28R4) IaA25R3 IaA28R4 IaA28R4
33537 (IaA28R4) IaA25R3 IaA28R4 IaA28R4
TU502 (IaA25R3) IaA25R3 IaA25R3 IaA25R3
*15/16 SNPs at the 3′ end of cgd6_60 are unique in 37999.
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members of multigene families usually play very important
biological functions [31,32]. The function of the MEDLE
family of secreted proteins in apicomplexan parasites has
not been examined. However, insulinase-like proteases
have been shown recently to be rhoptry or microneme-
associated in Toxoplasma gondii and are probably
involved in cell invasion [33,34]. Indeed, both cgd6_5510
and cgd6_5520 have peak expression during the invasion
process. The expression of cgd6_5480 and cgd6_ 5490 in
C. parvum may also be developmentally regulated, as they
showed identical expression patterns in in vitro culture
[29]. As sequence differences in non-coding regulatory
elements can also affect the timing or expression levels of
invasion-associated proteins, more studies are needed to
determine whether the duplications of MEDLE and insuli-
nase genes are indeed the cause of the host expansion of
in C. parvum.
Compared to the deletion of at least nine genes, C.
hominis appears to have only one unique gene that is
absent in C. parvum. This gene, Chro.50011, is located
at the 3′ end of chromosome 3 instead of the original
annotation at the 5′ end of chromosome 5 (Figure 2A).
It codes for a 489 aa hypothetical protein that contains
RS and HS repeats at the carboxyl end, and has recently
been identified as a C. hominis–specific gene, Chos-1, by
Bouzid and colleagues [35]. Although the function of the
protein is not clear, it has been suggested that this protein
is a member of a new Cryptosporidium-specific protein
family that are candidate mediators of host specificity and
virulence [35]. It remains to be determined whether the C.
hominis genome codes for additional species-specific
genes in areas of the ten sequence gaps in the C. parvum
IOWA genome.
Sequence similarity among C. hominis genomes and
genetic recombination in virulent C. hominis subtypes
As expected, much higher genetic similarity is present
among C. hominis genomes. The four C. hominis speci-
mens sequenced in this study had whole genome
sequences that are 99.72-99.83% similar to the published
C. hominis genome from TU502. Genes coding for some
secreted proteins (especially mucins) and proteasescontribute more to the sequence differences than others,
suggesting they are under selection and therefore may
serve as good targets for the development of diagnostic
tools and intervention measures. For example, some
of the polymorphic mucin genes such as cgd2_430
(Mucin5) and cgd6_1080 (gp60) are well known targets
of host immune responses [36,37] and have been used
widely in subtyping C. parvum and C. hominis [10].
Proteases (especially cysteine proteases) and protein ki-
nases have been recently shown to play important roles
in cell invasion of Cryptosporidium and thus have been
used as common targets in the development of thera-
peutic treatments [38-41].
In contrast to the relatively high nucleotide sequence
differences between the genomes sequenced in this study
and the published C. hominis TU502 genome, the
genomes of four specimens from two virulent C. hominis
subtypes (IbA10G2 and IaA28R4) in the United States
are very similar to each other except for the 3′ end of
chromosome 1 and three areas in chromosome 6. In
particular, chimeric sequences were seen in chromosome
6 (Table 6), indicating the occurrence of genetic recom-
bination in the two subtypes. One of the three areas with
genetic recombination is where gp60 (cgd6_1080) is
located, a locus widely known for its extremely high
sequence diversity and occurrence of genetic recombin-
ation [42]. Recently, population genetic analyses of
chromosome 6 sequences have shown the exclusive occur-
rence of genetic recombination in the virulent C. hominis
subtypes IbA10G2 and IaA28R4, especially around gp60
[43,44]. It was postulated that the fitness of the two sub-
types as a result of genetic recombination was likely
responsible for the wide dissemination of IbA10G2
around the world and the emergence of IaA28R4 in the
United States. The two IbA10G2 specimens sequenced in
this study also differ from each other at the 5′ end of
chromosome 6, especially in the ortholog of cgd6_60
(coding for a protease) as a result of genetic recombin-
ation. It was previously shown by MLST analysis of
chromosome 6 that IbA10G2 specimens from different
areas are genetically different [45]. Although the two
IaA28R4 specimens sequenced in this study are mostly
identical, data from a recent population genetic study of
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there are at least two origins of the subtype [44]. There-
fore, multiple genetic recombination events are probably
involved in the evolution of both IbA10G2 and IaA28R4
and are likely responsible for the observed emergence of
the same virulent gp60 subtypes in different geographical
locations in response to selection pressure [46]. The
occurrence of genetic recombination in virulent C.
hominis subtypes also suggests that the widely used gp60-
based typing alone is insufficient in molecular epidemio-
logic characterizations of field specimens, as pointed out
previously [46]. Therefore, the use of MLST and other
multilocus subtyping tools can provide new insights into
the transmission of Cryptosporidium spp. [44,47-49]. As
expected, the three loci in chromosome 6 where genetic re-
combination occurs, cgd6_60, cgd6_1080, and cgd6_5270
(coding for a hypothetical protein with a signal peptide and
paralogs) are all highly polymorphic in the present study.
The biological functions of proteins coded by cgd6_60 and
cgd6_5270 thus should be studied.
Conclusion
In conclusion, this comparative genomic analysis has
revealed some unique genetic differences between C.
parvum and C. hominis and identified some multigene
families that can potentially contribute to differences in
host specificity of the two closely related species. It has
further supported the potential role of genetic recombin-
ation in the emergence and evolution of virulent C.
hominis subtypes. Improvements in knowledge in these
two areas are still hampered by the lack of genomic stud-
ies of other Cryptosporidium species of significant public
health and economic importance, the incompleteness of
the reference C. parvum and C. hominis genomes, and
poor understanding of the functions of the thousands of
hypothetical proteins in Cryptosporidium genomes and
regulatory elements in non-coding areas. With the in-
creased recognition of the importance of cryptosporidiosis
in pediatric health in developing countries [3], common
occurrence of large waterborne outbreaks in industrialized
nations [15,16,50], and a major increase in cryptospor-
idiosis incidence in the United States in recent years
[6,8,9], more effort should be directed toward studies
on functional genomics and the basic biology of
Cryptosporidium spp. [51].
Methods
Cryptosporidium specimens
Four C. hominis specimens were used in whole genome
sequencing in the study: specimens 30974 and 37999 of
the IbA10G2 subtype and 30976 and 33537 of the
IaA28R4 subtype. Specimen 30974 was collected from a
patient from a cryptosporidiosis outbreak in July 2010 in
Columbia, South Carolina associated with a splash padthat had problems with filtration and chlorination. Test-
ing of filter backflush and stools from six patients all
identified the presence of the C. hominis IbA10G2 sub-
type. Specimen 30976 was collected from a patient in a
cryptosporidiosis outbreak in July 2010 in the St. Louis
area in Illinois and Missouri associated with swimming
pools and a water park. Testing of nine patient speci-
mens identified the occurrence of C. hominis IaA28R4
in seven patients, IaA24R4 in one patient, and IdA15G1
in another patient. Specimen 33537 was collected from a
patient from a cryptosporidiosis outbreak in July 2011 in
Walsenburg, Colorado associated with a waterpark that
had problems with the chlorinator. Testing of filter
backflush and stools from five patients identified
IaA28R4 in all. Specimen 37999 was collected from a
sporadic cryptosporidiosis patient in Twin Falls, Idaho in
September 2012. All stool specimens were collected
fresh from symptomatic patients and stored in 2.5%
potassium dichromate at 4°C prior to being used in
Cryptosporidium oocyst isolation for whole genome
sequencing within 6 months. Cryptosporidium species
and subtypes were determined by PCR-RFLP analysis of
the small subunit rRNA and sequence analysis of the
60 kDa glycoprotein (gp60) genes, respectively [17].
Oocyst isolation and whole genome amplification
Cryptosporidium oocysts were isolated from stool speci-
mens by discontinuous sucrose and cesium chloride
gradients as previously described [52]. They were further
purified by immunomagnetic separation using the Dyna-
beads Anti-Cryptosporidium kit (Invitrogen, Carlsbad,
CA). After treating the purified oocysts with 10%
commercial bleach on ice for 10 min and five cycles of
freezing and thawing, DNA was extracted from them by
using the Qiagen DNeasy Blood & Tissue Kit (Qiagen,
Valencia, CA). Whole genome amplification (WGA) of
the 25–100 ng of extracted DNA was conducted by
using the REPLI-g Midi Kit (Qiagen). The quality of the
WGA products was verified by sequencing BamHI-
digested WGA products cloned into a pUC19 vector
(Fermantas, Pittsburgh, PA). The sequencing was done
by using the ABI BigDye Terminator v3.1 Cycle Sequen-
cing Kit on an ABI3130 Genetic Analyzer (Applied Bio-
systems, Foster City, CA).
454 and Illumina sequencing and de novo contig
assembly
The WGA products from specimens 30974 and 33537 were
sequenced with 454 technology on a GS-FLX Titanium
System (Roche, Branford, CT) by using approximately 1 μg
of DNA for library construction and following standard
Roche library protocols, with an average insert size of
600 bp. One full PTP plate was used in the analysis of each
specimen. The sequence reads from each run were
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(http://www.454.com/products/analysis-software/) with the
default settings.
The WGA products from specimens 30976 and 37999
were used to generate Illumina TruSeq (v3) libraries (aver-
age insert size: 350 bp) and sequenced 100×100 bp paired-
end on an Illumina Genome Analyzer IIx (Illumina, San
Diego, CA). The sequence reads with a minimum quality
of 20 were trimmed by using CLC Assembly Cell 4.1.0
(http://www.clcbio.com/products/clc-assembly-cell/). The
data were then assembled with default parameters and a
minimum contig length of 500 bp, with scaffolding using
paired-end data.
Comparative genomic analyses
For comparisons of sequences at the genome level,
contigs of each specimen were aligned with reference se-
quences of the near complete genome of the C. parvum
IOWA isolate (version AAEE00000000.1) and the 1,422
contigs of the C. hominis TU5205 isolate (version
NZ_AAEL00000000.1) using Nucmer, a tool in MUMmer
3.23 (http://mummer.sourceforge.net/) [53]. Multiple gen-
ome alignments were also constructed by using the
progressive alginment algorithm of the Mauve 2.3.1
(http://asap.genetics.wisc.edu/software/mauve/) with de-
fault options [54]. In-house perl scripts were developed to
calculate the average nucleotide identities. For the detec-
tion of SNPs, Fastqc 0.10.0 (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/) was used for the QC
analysis of Illumina sequence reads, and PRINSEQ
0.20.3 (http://prinseq.sourceforge.net/) [55] was used to
remove low quality reads, with a min_qual_mean set-
ting of 20 and min_len of 65. Reads were then aligned
to reference sequences by using Bowtie 0.12.7 (http://bow-
tie-bio.sourceforge.net/index.shtml) [56]. The resulting
SAM files were processed, sorted and duplicates were
removed by using Picard 1.126 (http://broadinstitute.
github.io/picard/). The mpileup in SAMtools (http://sam-
tools.sourceforge.net/) was finally used to create the pileup
file for SNP variant calls using the mpileup2snp in VarScan
2.3.7 (http://varscan.sourceforge.net/) [57]. Default param-
eters for VarScan were used except that min-avg-qual was
set to 30.
PCR verification
As the comparative genomic analysis had identified some
nucleotide sequences (AAEL01000413, AAEL01000728,
and AAEL01000717) in the published C. hominis that had
not been seen in the published C. parvum genome,
primers were designed based on these sequences to verify
the source of these sequences by PCR (Additional file 6:
Table S1). Five specimens each of C. parvum and C. homi-
nis were used in PCR analysis of each target. In addition,
two C. andersoni specimens were used in confirmation ofCryptosporidium-origin of contig AAEL01000728. Each
specimen was analyzed in duplicate nested PCR using
50 μl PCR mixture consisting of 1 μl (~100 ng) of ex-
tracted DNA or 2 μL of primary PCR products (in second-
ary PCR), 200 μM deoxynucleoside triphosphate, 1× PCR
buffer (Applied Biosystems), 3.0 mM MgCl2, 5.0 U of Taq
polymerase (Promega, Madison, WI), 100 nM primers,
and 400 ng/μl of non-acetylated bovine serum albumin
(Sigma-Adrich, St. Louis, MO). The primary and second-
ary PCR reactions were performed in a GeneAmp PCR
9700 thermocycler (Applied Biosystems) for 35 cycles of
94°C for 45 s, 55°C for 45 s, and 72°C for 60 s, with an
initial denaturation (94°C for 5 min) and a final exten-
sion (72°C for 7 min). The secondary PCR products
were sequenced in both directions using Sanger technol-
ogy described above. Nucleotide sequences obtained were
aligned with reference sequences downloaded from Gen-
Bank by using ClustalX (http://www.clustal.org/).
NCBI BioProject No.
Nucleotide sequences generated from the project, in-
cluding all SRA data and assembled contigs, were sub-
mitted to the NCBI BioProject under the accession
number PRJNA252787.
Ethics statement
The study was done on delinked residual diagnostic
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No. 990115 “Use of residual human specimens for the
determination of frequency of genotypes or sub-types of
pathogenic parasites”, which was reviewed and approved
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Disease Control and Prevention (CDC). No personal
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Additional files
Additional file 1: Figure S1. Coverage of two Roche 454 sequenced
genomes of Cryptosporidium hominis comparing to the published C.
parvum (IOWA) and C. hominis (TU502) genomes. The eight
chromosomes of C. parvum are numbered and assembled contigs are
bordered by vertical red lines. The color blocks are conserved segments
of sequences internally free from genome rearrangements, whereas the
inverted white peaks within each block are sequence divergence
between the reference C. parvum genome and C. hominis genome under
analysis.
Additional file 2: Figure S2. Sequence divergence between
Cryptosporidium hominis IaA28R4 (specimen 30976) and IaA25R3 (isolate
TU502) subtypes by chromosome. The number of the SNPs in a sliding
window of 2,000 bp with 200 bp steps across each of the eight
chromosomes is shown.
Additional file 3: Figure S3. Polymorphic nucleotide sequences in mid
part of the Chro.60016 (ortholog of cgd6_60, coding for a protease) gene
in Cryptosporidium hominis specimens. Dots denote sequence identity to
the reference TU502 sequence. Specimen 37999 also has different
sequence at the 3′ end of the gene (not shown).
Guo et al. BMC Genomics  (2015) 16:320 Page 17 of 18Additional file 4: Figure S4. Lack of variation in sequence diversity in
the trinucleotide repeat region in the gp60 gene of specimen 30974 of
the Cryptosporidium hominis IbA10G2 subtype. Of 205 reads from 454
sequencing that mapped to gp60, 78 had complete sequence of the
trinucleotide repeats, with no variation in repeat numbers. Dots denote
sequence identity to the reference sequence, whereas dashes denote
deletions of nucleotides.
Additional file 5: Figure S5. Lack of variation in sequence diversity in
the trinucleotide repeat region in the gp60 gene of specimen 33537 of
the Cryptosporidium hominis IaA28R4 subtype. Of 310 reads from 454
sequencing that mapped to gp60, 59 had complete sequence of the
trinucleotide repeats, with no variation in repeat numbers. Dots denote
sequence identity to the reference sequence, whereas dashes denote
deletions of nucleotides.
Additional file 6: Table S1. Primers used in the PCR verification of
possible Cryptosporidium hominis-unique nucleotide sequences.
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